Delivery Order SPE2DB20D1100-SPE2DB25FD9S6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $1,126.10 and a firm fixed price contract type. This delivery order, which is expected to be completed by August 11, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,259.24 for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded procurement issued on July 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a specialized acute-use nasal spray medication, indicating this delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 10 mg nasal sprays with a ceiling value of $1,441.57. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child delivery order under a larger contract vehicle....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,300.40 on August 14, 2025, for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $2,114.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 15 mg nasal sprays. The contract employs firm fixed-price pricing and is scheduled for completion by August 15, 2025. This non-competitive delivery order will be fulfilled from the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9S6Delivery Order
This delivery order, awarded on August 11, 2025, to AmerisourceBergen Drug Corp, provides Valtoco (naloxone) 15 mg nasal spray to support federal medical supply needs. The contract, valued at $10,270.32 with a firm fixed price structure, is scheduled for completion by August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency (DLA), a Department of Defense organization, is the funding federal agency. No set-aside designation was applied to this award, indicating it was competitively awarded. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has an extensive federal contract portfolio with DLA and serves critical healthcare supply needs for military and veteran systems. The Valtoco nasal spray delivery supports emergency medical response capabilities, as naloxone is an opioid antagonist used for opioid overdose reversal. The firm's position as a comprehensive pharmaceutical prime vendor enables it to fulfill varied medical supply requirements across multiple therapeutic domains, and this particular delivery order reflects the company's ongoing role in maintaining critical emergency pharmaceutical inventories within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 8/11/25 |